Page last updated: 2024-10-25

r 59022 and Leukemia, T-Cell

r 59022 has been researched along with Leukemia, T-Cell in 1 studies

R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist

Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with thapsigargin, a microsomal Ca2+-ATPase inhibitor, abolished the rises of [Ca2+]i induced by the subsequent addition of sphingosine, OKT3, and PA in the absence of extracellular Ca2+."1.29Ca2+ mobilizing action of sphingosine in Jurkat human leukemia T cells. Evidence that sphingosine releases Ca2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate. ( Imoto, K; Kaneko, M; Ohshika, H; Sakano, S; Takemura, H; Yamada, K, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakano, S1
Takemura, H1
Yamada, K1
Imoto, K1
Kaneko, M1
Ohshika, H1

Other Studies

1 other study available for r 59022 and Leukemia, T-Cell

ArticleYear
Ca2+ mobilizing action of sphingosine in Jurkat human leukemia T cells. Evidence that sphingosine releases Ca2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate.
    The Journal of biological chemistry, 1996, May-10, Volume: 271, Issue:19

    Topics: Amines; Calcium; Cell Line; Ceramides; Diacylglycerol Kinase; Diglycerides; Enzyme Inhibitors; Human

1996